Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the start, our focus has been on building bridges to the pharmaceutical markets of Central Eastern Europe. Much has changed in the region since 1959 – both economically and politically – and over this period we have gained an in-depth understanding of the markets and an esteemed standing there.
While we started out purely as a marketing partner for pharmaceutical companies, we have since acquired and launched proprietary products. Our brand Revalid® – a product line for holistic hair care and hair loss treatment–was developed in 1992 in Switzerland. In 2011, we acquired Irish healthcare company Newport Pharmaceuticals Ltd. giving us full ownership of the antiviral drug Isoprinosine® in 2011.Overseen by our head office in Schaffhausen, Switzerland, we now channel our industry knowledge and experience into the successful placement of both Ewopharma and partner brands in our target markets. In 2004, we joined the RX-Alliance, a professional cooperation network of successful pharmaceutical companies active in selected European markets.

Pharmaceutical

Ewopharma

Alain Staub

Reto Schaberl

Antonio Mantarro

Andreas Kübler

The Product Management Team at Ewopharma is responsible for the strategic development and lifecycle management of the company's portfolio, including proprietary products like Revalid® and Isoprinosine®. They conduct market research, identify consumer needs, and collaborate with cross-functional teams to optimize product positioning and ensure successful launches in Central Eastern European markets. Their focus is on driving growth and maximizing the impact of both Ewopharma’s own brands and partner products within the competitive pharmaceutical landscape.

Product Management Team

Marketing and Sales

Business Management

Medical and Regulatory Affairs

Product Management Team

About

Team members

Other teams at Ewopharma

Marketing and Sales

Business Management

Medical and Regulatory Affairs